Polyunsaturated Fatty Acids and Stage III Non-Small Cell Lung Cancer
Written by Dr Michael Lange on March 28, 2011
Polyunsaturated Fatty Acids and Stage III Non-Small Cell Lung Cancer
Oral Nutritional Supplements Containing (n-3) Polyunsaturated Fatty Acids Affect the Nutritional Status of Patients with Stage III Non-Small Cell Lung Cancer during Multimodality Treatment.
van der Meij BS, Langius JA, Smit EF, Spreeuwenberg MD, von Blomberg BM, Heijboer AC, Paul MA, van Leeuwen PA.
Department of Nutrition and Dietetics, Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands.
Abstract
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), (n-3) fatty acids from fish oil, have immune-modulating effects and may improve nutritional status in cancer. The objective of this study was to investigate the effects of an oral nutritional supplement containing (n-3) fatty acids on nutritional status and inflammatory markers in patients with non-small cell lung cancer (NSCLC) undergoing multimodality treatment. In a double-blind experiment, 40 patients with stage III NSCLC were randomly assigned to receive 2 cans/d of a protein- and energy-dense oral nutritional supplement containing (n-3) fatty acids (2.0 g EPA + 0.9 g DHA/d) or an isocaloric control supplement. EPA in plasma phospholipids, energy intake, resting energy expenditure (REE), body weight, fat free mass (FFM), mid-upper arm circumference (MUAC), and inflammatory markers were assessed. Effects of intervention were analyzed by generalized estimating equations and expressed as regression coefficients (B). The intervention group (I) had a better weight maintenance than the control (C) group after 2 and 4 wk (B = 1.3 and 1.7 kg, respectively; P < 0.05), a better FFM maintenance after 3 and 5 wk (B = 1.5 and 1.9 kg, respectively; P < 0.05), a reduced REE (B = -16.7% of predicted; P = 0.01) after 3 wk, and a trend for a greater MUAC (B = 9.1; P = 0.06) and lower interleukin-6 production (B = -27.9; P = 0.08) after 5 wk. After 4 wk, the I group had a higher energy and protein intake than the C group (B = 2456 kJ/24 h, P = 0.03 and B = 25.0 g, P = 0.01, respectively). In conclusion, a protein- and energy-dense oral nutritional supplement containing (n-3) fatty acids beneficially affects nutritional status during multimodality treatment in patients with NSCLC.
Original publication at PubMed
Order Fortifeye™ vitamins by clicking below:
  |
Fortifeye™ Complete Plus is an advanced formulation based on the latest clinical studies. It is a combination of synergistically blended whole foods, phytonutients, vitamins, minerals, enzymes and essential fatty acids. When combined with proper diet, exercise and a healthy life style Fortifeye™ Complete Plus lays the foundation for good eye and total body health. Dosage: 2 tablets + 1 softgel/day |
  |
Fortifeye™ Super Omega 3 Fish Oil Fortifeye™ Super Omega-3 Fish Oil is the newest, most concentrated and purified Omega Three Fish Oil by Fortifeye™ Take Fortifeye™ Super Omega-3 in conjunction with Fortifeye™ Complete Plus for more intensive nutritional therapy. Dosage: 2 softgels/day |
  |
Fortifeye™ FOCUS is a combination of three carotenoids—astaxanthin, lutein and zeaxanthin. Clinical studies indicate that 6mg of astaxanthin reduces eye fatigue symptomology and actually improves amplitude of accommodation, the eye’s ability to focus clearly on objects at near distances. This new formulation was developed to help reduce accommodative stress due to prolonged working at a near focal length. Fortifeye FOCUS is recommended for individuals who experience eye fatigue with near point tasks or after prolonged work on a computer. Fortifeye FOCUS can be used alone or in combination with any of the Fortifeye™ Vitamins. Dosage: 1 softgel per day |
  |
Fortifeye™ Complete Fortifeye™ Complete One-A-Day is a powerhouse combination of 50 total body and vision specific nutrients all combined into one USP certified tablet. Fortifeye™ Complete One-A-Day multivitamin has been created by doctors who understand that quality counts. Fortifeye™ Complete One-A-Day can be used alone or in combination with Fortifeye™ Super Omega 3 Fish Oil or Fortifeye™ Dry Eye Therapy Extreme to combat against free radical damage in the eyes and body. Dosage: 1 tablet per day |
  |
Fortifeye™ Complete Macular Defense Fortifeye™ Complete Macular Defense vitamins are the newest, most advanced nutraceuticals for your eyes and body, which provide purified Natural Triglyceride omega three fish oil, along with lutein and zeaxanthin for vision support. This formula provides the equivalent in antioxidant power to 15-17 servings of fruits and vegetables a day, 30 mg of lutein and 4.75 mg of zeaxanthin. Dosage: 3 tablets + 1 softgel/day |
|
Article about Fortifeye™ Complete One-A-Day Multivitamin. Read more about Fortifeye™ Complete One-A-Day Multivitamin and the science behind this newest, most advanced nutraceutical for your eyes and body.
|
|
All Fortifeye products are produced in a GMP, FDA and NNFA inspected facility that supplies products to the nutraceutical industry. Fortifeye is also approved by the Therapeutics Goods Association, the leading regulatory authority for nutraceuticals world wide and by NSF.
|
|
Learn how to support good eye and total body health. Read more about the full line of Fortifeye™ vitamin and mineral supplements—the newest, most advanced nutraceuticals for your eyes and body.
|
